BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Stoke Therapeutics

Stoke Therapeutics logo

Founded
2014
Geography
United States of America based
Funding
$130 M

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.

Technologies

Antisense Oligonucleotides  


Posts Mentioning This Company

R&D Platform

-


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet